Response to an adequate dietary intake of vitamin D3 modulates the effect of estrogen therapy on bone density

Journal of Women's Health

Volumn 21, Issue 8, 2012, Pages 858-864

  Schnatz, Peter F ^a,b   Marakovits, Kimberly A ^a,c   O'Sullivan, David M ^a   Ethun, Kelly ^d   Clarkson, Thomas B ^d   Appt, Susan E ^d  

^a READING HOSPITAL AND MEDICAL CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; COLECALCIFEROL; CONJUGATED ESTROGEN;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; BONE DENSITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG POTENTIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN THERAPY; FEMALE; HAPLORHINI; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGULATORY MECHANISM; TREATMENT RESPONSE; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

ANIMALS; ANTIFIBRINOLYTIC AGENTS; BODY MASS INDEX; BONE DENSITY; CHOLECALCIFEROL; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; ESTROGENS, CONJUGATED (USP); HEMOSTATICS; LONGITUDINAL STUDIES; MACACA FASCICULARIS; MODELS, ANIMAL; POSTMENOPAUSE; VITAMIN K 2; VITAMINS;

EID: 84864645895     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2011.3244     Document Type: Article

References (36)

1. Pittas AG, Dawson-Hughes B. Vitamin D and diabetes. J Steroid Biochem Mol Biol 2010;121:425-429.
2. von Hurst PR, Stonehouse W, Coad J. Vitamin D supple-mentation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient\A randomized, placebo-controlled trial. Br J Nutr 2010;103:549-555.
3. Wong KE, Szeto FL, Zhang W, et al. Involvement of the vitamin D receptor in energy metabolism: Regulation of uncoupling proteins. Am J Physiol Endocrinol Metab 2009;296:E820-828.
4. Chen S, Glenn DJ, Ni W, et al. Expression of the vitamin D receptor is increased in the hypertrophic heart. Hyperten-sion 2008;52:1106-1112.
5. 2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009;120:687-698.
6. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117: 503-511.
7. Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugame S. Plasma vitamin D and risk of colorectal cancer: The Japan public health center-based prospective study. Br J Cancer 2007;97:446-451.
8. Li H, Stampfer MJ, Hollis JB, et al. A prospective study of plasma vitamin D metabolites, vitamin D receptor poly-morphisms, and prostate cancer. PLoS Med 2007;4e103.
9. Garland CF, Gorham ED, Mohr SB, et al. Vitamin D and prevention of breast cancer: Pooled analysis. J Steroid Bio-chem Mol Biol 2007;103:708-711.
10. Ross AC, Taylor CL, Yaktine AL, Del Valle HB, eds., Com-mittee to Review Dietary Reference Intakes for Vitamin D and Calcium; Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Available at books.nap.edu/openbook.php?record-id=13050&page=R1 Accessed March 28, 2012.
11. Institute of Medicine, Committee to Review Dietary Re-ference Intakes for Vitamin D and Calcium. Brief report, November 2010. Dietary reference intakes for calcium and vitamin D. Available at www.iom.edu/~/media/Files/ Report%20Files/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D/ Vitamin%20D%20and%20Calcium%202010% 20Report%20Brief.pdf Accessed March 28, 2012.
12. Yusupov E, Li-Ng M, Pollack S, Yeh JK, Mikhail M, Aloia JF. Vitamin D and serum cytokines in a randomized clinical trial. Int J Endocrinol 2010, Article ID 305054, 7 pages; doi:10.1155/2010/305054.
13. International Osteoporosis Foundation (IOF). IOF position statement: Vitamin D recommendations for older adults\Position paper. Available at www.natap.org/2010/HIV/072310-01.htm Accessed March 28, 2012.
14. National Osteoporosis Foundation. Prevention: Vitamin D and bone health. Available at www.nof.org/aboutosteo-porosis/prevention/vitamind Accessed March 28, 2012.
15. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evalua-tion, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin En-docrinol Metab 2011;96:1911-1930.
16. North American Menopause Society. Management of oste-oporosis in postmenopausal women: 2010 position state-ment. Menopause 2010;17:25-54.
17. Ginde AA, Liu MC, Camargo CA. Demographic differences and trends of vitamin D insufficiency in the U.S. population, 1988-2004. Arch Intern Med 2009;169:626-632.
18. Hunter D, De Lange M, Snieder H, et al. Genetic contribu-tion to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation. J Bone Miner Res 2001;16:371-378.
19. Karohl C, Su S, Kumari M, et al. Heritability and seasonal variability of vitamin D concentrations in male twins. Am J Clin Nutr 2010;92:1393-1398.
20. Wang TJ, Zhang F, Richards JB, et al. Common genetic de-terminants of vitamin D insufficiency: A genome-wide as-sociation study. Lancet 2010;376:180-188.
21. Gutiérrez OM, Farwell WR, Kermah D, Taylor EN. Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey. Available at www.natap.org/2010/HIV/aframericansbone.pdfAccessed March 28, 2012.
22. Jerome C. Hormonal therapies and osteoporosis. ILAR J 2004;45:170-178.
23. Smith SY, Jollette J, Turner CH. Skeletal health: Model of postmenopausal osteoporosis. Am J Primatol 2009;71: 752-765.
24. Jerome CP, Turner CH, Lees CJ. Decreased bone mass and strength in ovariectomized cynomolgus monkeys (Macaca fascicularis). Calcif Tissue Int 1997;60:265-271.
25. Jerome CP, Peterson PE. Nonhuman primate models in skeletal research. Bone 2001;29:1-6.
26. Burr DB, Hirano T, Turner CH, Hotchkiss C, Brommage R, Hock JM. Intermittently administered human parathyroid hormone (1-34) treatment increases intracortical bone turn-over and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys. J Bone Miner Res 2001;16:157-165.
27. Fox J, Newman MK, Turner CH, Guldberg RE, Varela A, Smith SY. Effects of treatment with parathyroid hormone 1-84 on quantity and biomechanical properties of thoracic vertebral trabecular bone in ovariectomized rhesus mon-keys. Calcif Tissue Int 2008;82:212-220.
28. Jayo MJ, Register TC, Carlson CS. Effects on bone of oral hormone replacement therapy initiated 2 years after ovari-ectomy in young adult monkeys. Bone 1998;23:361-366.
29. Jerome CP, Carlson CS, Register TC, et al. Bone functional changes in intact, ovariectomized, and ovariectomized, hormone-supplemented adult cynomolgus monkeys (Maca-ca fascicularis) evaluated by serum markers and dynamic histomorphometry. J Bone Miner Res 1994;9:527-540.
30. The North American Menopause Society. Disease risk: Os-teoporosis. In: Menopause practice: A clinician's guide, 4th ed. Mayfield Heights, OH: NAMS, 2010:5.9-5.20.
31. Kuwamura Y, Kakehi K, Hirakawa K, Miyajima H. Ectopic uterine ovarian tissue in cynomolgus monkeys. Toxicol Pa-thol 2006;34:220-222.
32. Steege JF. Ovarian remnant syndrome. Obstet Gynecol 1987;70:64-67.
33. Lane NE. Epidemiology, etiology, and diagnosis of osteo-porosis. Am J Obstet Gynecol 2006;194(Suppl):S3-11.
34. Lees CJ, Kaplan JR, Chen H, Jerome CP, Register TC, Franke AA. Bone mass and soy isoflavones in socially housed, premenopausal macaques. Am J Clin Nutr 2007;86:245-250.
35. Wells G, Tugwell P, Shea B, et al, for the Osteoporosis Methodology Group and the Osteoporosis Research Ad-visory Group. Meta-analyses of therapies for postmeno-pausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev 2002;23:529-539.
36. Cauley JA, Robbins J, Chen Z, et al, for the Women's Health Initiative Investigators. Effects of estrogen plus progestin on risk of fracture and bone mineral density: The Women's Health Initiative randomized trial. JAMA 2003;290:1729-1738.